This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Northwestern University. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Innovations of Janina Luciano in Nanotechnology
Introduction
Janina Luciano is an accomplished inventor based in Champaign, IL (US). She has made significant contributions to the field of nanotechnology, particularly in the development of nanoconjugates that can effectively cross the blood-brain barrier. With a total of two patents to her name, her work addresses critical challenges in therapeutic applications for central nervous system disorders.
Latest Patents
Luciano's latest patents focus on nanoconjugates that are designed to cross the blood-brain barrier. One of her notable inventions is a polyvalent nanoconjugate that effectively targets therapeutic use. This single-entity, targeted therapeutic is capable of crossing the blood-brain barrier (BBB), making it a promising solution for treating central nervous system (CNS) disorders. Importantly, despite the high cellular uptake of these nanoconjugates, they exhibit no toxicity in the tested cell types. This characteristic is crucial for therapeutic agent delivery applications, as it helps to reduce off-target effects.
Career Highlights
Janina Luciano is affiliated with Northwestern University, where she continues her research and development in nanotechnology. Her innovative work has positioned her as a key figure in the field, contributing to advancements that could revolutionize treatment options for CNS disorders.
Collaborations
Luciano has collaborated with notable researchers such as Chad A. Mirkin and Caroline H. Ko. These collaborations have further enhanced her research capabilities and have led to significant advancements in her field.
Conclusion
Janina Luciano's contributions to nanotechnology, particularly in developing nanoconjugates that cross the blood-brain barrier, highlight her innovative spirit and dedication to improving therapeutic applications. Her work promises to pave the way for new treatment options for central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
